SRNE (SRNE) Stock Price & Analysis
SRNE (SRNE) rose 0.00% to USD 0 as of July 25, 2026 at 03:06 UTC, according to Nexqual real-time market data.
SRNE last closed at USD 0; the session ranged USD 0.01–0.01 on volume of 501,682 shares. Market capitalization is —, with a 52-week range of USD 0–0.1 (PNK). Source: Nexqual, July 25, 2026 at 03:06 UTC.
Key Statistics (as of July 25, 2026 at 03:06 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0.01 – 0.01 |
| 52-Week Range | USD 0 – 0.1 |
| Volume | 501,682 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (SRNE)
Nexqual's technical model rates SRNE "STRONG BUY" based on 4 bullish and 0 bearish signals across 124 daily candles, as of July 25, 2026 at 03:06 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 52.59 (neutral) |
| vs SMA50 | Above (USD 0) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| VXRT | Vaxart, Inc. | USD 0.5 | ▲ 3.13% |
| INO | Inovio Pharmaceuticals, Inc. | USD 0.97 | ▼ 8.49% |
| IBIO | iBio, Inc. | USD 1.43 | ▲ 3.62% |
| NVAX | Novavax, Inc. | USD 7.46 | ▼ 5.69% |
| CODX | Co-Diagnostics, Inc. | USD 2.1 | ▼ 7.89% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 03:06 UTC. This page is informational and not investment advice.